Patent Approval for Products of Living Cell Technologies and HealthLinx

Encapsulation technology, IMMUPEL, by Living Cell Technologies (ASX:LCT) has received an Australian patent , while HealthLinx (ASX:HTX) has received a UK patent for its OvPlex diagnostic technology.

IMMUPEL holds the technology for encapsulation of living cells, which can be transplanted into patients. Since the encapsulated cells are protected from the immune system, there is no need for immunosuppressant drugs. An example of this technology is LCT's DIABECELL, which encapsulates porcine insulin-producing cells, that are later injected into patients with Type 1 diabetes.

'Night Milk' Patented By German Company to Help You Get Good Shuteye
A German company has patented its product -'night milk' taken from cows, which helps improve sleep.

HealthLinx (ASX:HTX), the Melbourne-based company has also received patent approval for its OvPlex diagnostic product from the UK patent office. The product basically searches for biomarkers in a sample of blood to detect the presence of ovarian cancer.

Source-Medindia

China�s Bid to Patent Pudina Foiled
In an audacious move, China had moved to patent the health benefits of pudina, but this bid was foiled by India

US Stem Cell Research is Being Hindered by Rush for Patents
Experts have said that cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked

Amazon Patents Process to Avoid Unwanted Gifts
Online retailer Amazon.com has come up with a procedure, which will allow recipients to stay away from undesirable gifts and save millions of dollars spent on repacking, labeling and shipping.